Teva Pharmaceutical (Germany) Performance
| TEV Stock | 20.40 1.20 5.56% |
On a scale of 0 to 100, Teva Pharmaceutical holds a performance score of 9. The entity has a beta of 0.17, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Teva Pharmaceutical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Teva Pharmaceutical is expected to be smaller as well. Please check Teva Pharmaceutical's kurtosis, and the relationship between the downside variance and day median price , to make a quick decision on whether Teva Pharmaceutical's existing price patterns will revert.
Risk-Adjusted Performance
9 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Teva Pharmaceutical Industries are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Teva Pharmaceutical unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 2.2 B | |
| Free Cash Flow | 1 B |
Teva |
Teva Pharmaceutical Relative Risk vs. Return Landscape
If you would invest 1,580 in Teva Pharmaceutical Industries on October 8, 2024 and sell it today you would earn a total of 460.00 from holding Teva Pharmaceutical Industries or generate 29.11% return on investment over 90 days. Teva Pharmaceutical Industries is generating 0.4986% of daily returns and assumes 3.9396% volatility on return distribution over the 90 days horizon. Simply put, 35% of stocks are less volatile than Teva, and 91% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Teva Pharmaceutical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Teva Pharmaceutical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Teva Pharmaceutical Industries, and traders can use it to determine the average amount a Teva Pharmaceutical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1266
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | TEV | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.94 actual daily | 35 65% of assets are more volatile |
Expected Return
| 0.5 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 9 91% of assets perform better |
Based on monthly moving average Teva Pharmaceutical is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Teva Pharmaceutical by adding it to a well-diversified portfolio.
Teva Pharmaceutical Fundamentals Growth
Teva Stock prices reflect investors' perceptions of the future prospects and financial health of Teva Pharmaceutical, and Teva Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Teva Stock performance.
| Current Valuation | 28.17 B | |||
| Price To Book | 1.18 X | |||
| Price To Sales | 0.68 X | |||
| Revenue | 14.93 B | |||
| EBITDA | (827 M) | |||
| Total Debt | 19.1 B | |||
| Cash Flow From Operations | 1.59 B | |||
| Total Asset | 44.01 B | |||
About Teva Pharmaceutical Performance
Assessing Teva Pharmaceutical's fundamental ratios provides investors with valuable insights into Teva Pharmaceutical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Teva Pharmaceutical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Teva Pharmaceutical performance evaluation
Checking the ongoing alerts about Teva Pharmaceutical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Teva Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Teva Pharmaceutical had very high historical volatility over the last 90 days | |
| Teva Pharmaceutical has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 14.93 B. Net Loss for the year was (2.35 B) with profit before overhead, payroll, taxes, and interest of 0. |
- Analyzing Teva Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Teva Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining Teva Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Teva Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Teva Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Teva Pharmaceutical's stock. These opinions can provide insight into Teva Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Teva Stock Analysis
When running Teva Pharmaceutical's price analysis, check to measure Teva Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharmaceutical is operating at the current time. Most of Teva Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Teva Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharmaceutical's price. Additionally, you may evaluate how the addition of Teva Pharmaceutical to your portfolios can decrease your overall portfolio volatility.